There are a large number of investors who feel this piece is a hit piece and are very frustrated with your decision to publish this author AND to give the article a Pro Pick. (You lost a lot of credibility with same posters by doing so).
Read the re-posts under that article where a someone reposted a 4 part response written by sdrawkcabeman in another blog. He is recognized as being very knowledgeable on the science and trial protocol and analysis and specifically, Geron's trials. You can use his detailed responses to the article as your basis for judging whether or not Alpha Exposure's article should have been taken for fact like it was ... or whether it deserved more detailed scrutiny by the person who made thhe decision to first publish it ... and then second to give it a pro pick. From investor's point of view, you enabled this short manipulation especially because I am positive this same author has been brought to your attention previously with the exact same complaint.
There are a large number of investors who feel this piece is a hit piece and are very frustrated with your decision to publish this author AND to give the article a Pro Pick. (You lost a lot of credibility with same posters by doing so).
Read the re-posts under that article where a someone reposted a 4 part response written by sdrawkcabeman in another blog. He is recognized as being very knowledgeable on the science and trial protocol and analysis and specifically, Geron's trials. You can use his detailed responses to the article as your basis for judging whether or not Alpha Exposure's article should have been taken for fact like it was ... or whether it deserved more detailed scrutiny by the person who made thhe decision to first publish it ... and then second to give it a pro pick. From investor's point of view, you enabled this short manipulation especially because I am positive this same author has been brought to your attention previously with the exact same complaint.